OPK
OPKO HEALTH, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.59
−3.05%Price chart
Aug 7Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
27.5x
Market Cap
$1.19B
MomentumView details →
1D Return
−3.05%
YTD Return
+23.39%
RSI (14)
57.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
27.5x
Market Cap
$1.19B
RSI (14)
57.1
MomentumView details →
1D Return
−3.05%
YTD Return
+23.39%
SummaryUpdated Jun 1, 2026
OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company founded in 1991 and headquartered in Miami, Florida. The company went public in 1995 and operates through two primary business segments: diagnostics and pharmaceuticals. OPKO has evolved from a traditional pharmaceutical company into a broader healthcare enterprise that combines laboratory testing services with drug development and commercialization. The company operates internationally across the United States, Ireland, Chile, Spain, Israel, and Mexico, serving healthcare providers, patients, and pharmaceutical partners through its integrated platform of diagnostic services and therapeutic products.
Similar companies
Latest newsMore news →
OPKO Health secured $125 million in financing against its mazdutide royalties, obtaining non-dilutive capital while retaining longer-term royalty upside.21d agoOPKO Health issued $125 million in notes to HealthCare Royalty, secured by royalty interests in Mazdutide, to raise non-dilutive capital.26d agoCocrystal Pharma announced a $5 million private placement with OPKO Health, which increased its investment in the company.37d ago